angiotensin ii has been researched along with apigenin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Jia, CH; Wang, F; Xie, ML; Zhu, ZY | 1 |
2 other study(ies) available for angiotensin ii and apigenin
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Apigenin-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngⅡ/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells.
Topics: Angiotensin II; Animals; Apigenin; Atrial Natriuretic Factor; Cardiomegaly; Cell Hypoxia; Cell Line; Down-Regulation; Glucose; Glucose Transporter Type 4; Hypoxia-Inducible Factor 1, alpha Subunit; Myocytes, Cardiac; PPAR alpha; PPAR gamma; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Up-Regulation | 2019 |